Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of APL180 on endothelial function in familial hypercholesterolemia
2008-002848-41Phase 2Terminated
- Sponsor
- Novartis
- Start
- Aug 2008
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in familial hypercholesterolemia (FH) comparing APL180 ascending dose with Placebo (2 arms). Primary endpoint: Percent change in forearm blood flow after acetylcholine or sodium nitroprusside infusion. Started Aug 2008; status: terminated.
02
Drugs
APL180
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on 2008-002848-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002848-41.